Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D. Subirá, E. Alonso, J.I. Martínez, J. Jara, C. Hernández.
Terapia antiandrogénica como quimioprevención del cáncer de próstata.
SEMERGEN, 30 (2004), pp. 190-192
[2.]
D.F. Ransohoff, M.M. Collins, F.J. Fowler.
Why is prostate cancer so common when the evidence is so uncertain? A system without negative feedback.
Am J Med, 113 (2002), pp. 663-667
[3.]
G. Lu-Yao, P.C. Albertsen, J.L. Stanford, T.A. Stukel, E.S. Walker-Corker, M.J. Barry.
Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seatle area and Connecticut.
BMJ, 325 (2002), pp. 740-746
[4.]
F.J. Fowler, M.M. Collins, E.W. Corkery, D.B. Elliot, M.J. Barry.
The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
Cancer, 95 (2002), pp. 287-295
[5.]
L. Holmberg, A. Bill-Axelson, F. Helgesen, J.O. Salo, P. Folmerz, M. Häggman, et al.
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
N Engl J Med, 347 (2002), pp. 781-789
[6.]
P.C. Walsh.
Surgery and the reduction of mortality from prostate cancer.
N Engl J Med, 347 (2002), pp. 839-840
[7.]
F.H. Schröder.
Priorities in future research in prostate cancer screening.
Eur J Epidemiol, 18 (2003), pp. 1021-1023
[8.]
A.J. Coldman, N. Phillips, T.A. Pickles.
Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.
CMAJ, 168 (2003), pp. 31-35
[9.]
I.M. Thompson, P.J. Goodman, C.M. Tangen, M.S. Lucia, G.J. Miller, L.G. Ford, et al.
The influence of finasteride on the development of prostate cancer.
N Engl J Med, 349 (2003), pp. 215-224
[10.]
P.T. Scardino.
The prevention of prostate cancer. The dilemma continues.
N Engl J Med, 349 (2003), pp. 297-299
[11.]
A. Morgentaler, C.O. Brunning, W.C. DeWolf.
Occult prostate cancer in men with low serum testosterone levels.
JAMA, 276 (1996), pp. 1904-1906
[12.]
J.T. Isaacs, W.B. Isaacs.
Androgen receptor outwits prostate cancer drugs.
Nature Biol, 10 (2004), pp. 26-27
[13.]
J. Gérvas.
Quimioprofilaxis en el siglo XXI. Algunos problemas del uso de medicamentos para la prevención primaria de enfermedades.
FMC, 10 (2003), pp. 680-683
Copyright © 2004. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
